SCHEMBL20845181

SCHEMBL20845181

C1=C\c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2-c2cc3oc4ccccc4c3cc2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.31

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.31
▸ MAPT P10636 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ NFKB2 Q00653 1/20 0.30
▸ RELA Q04206 1/20 0.30
▸ ATM Q13315 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ MMP12 P39900 1/20 0.30
▸ MMP13 P45452 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845055 0.99 AHR (0.32) AHRMAPTKDM4EALDH1A1TP53
SCHEMBL20845186 0.97 — —
SCHEMBL20845182 0.97 PLA2G2A (0.32) MAPTKDM4EALDH1A1TP53HPGD
SCHEMBL20845097 0.93 KMT2A (0.33) MAPTKDM4EALDH1A1HPGDMAPK1
SCHEMBL20845338 0.93 KMT2A (0.32) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL20845187 0.93 ALDH1A1 (0.35) MAPTKDM4EALDH1A1TP53HPGD
SCHEMBL20845081 0.89 MEN1 (0.31) MAPTKDM4EALDH1A1HPGD
SCHEMBL20845080 0.89 — —
SCHEMBL20845101 0.89 MEN1 (0.31) MAPTALDH1A1HPGD
SCHEMBL20222682 0.88 MAPT (0.34) AHRMAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 AHR 270/4885MAPT 4294/4885KDM4E 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback